Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $199.22 million. The enterprise value is $322.13 million.

Market Cap	199.22M
Enterprise Value	322.13M

Important Dates

The next estimated earnings date is Monday, March 30, 2026, before market open.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

GALT has 64.47 million shares outstanding. The number of shares has increased by 2.12% in one year.

Current Share Class	64.47M
Shares Outstanding	64.47M
Shares Change (YoY)	+2.12%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	20.34%
Owned by Institutions (%)	18.38%
Float	45.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.10

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-87.09%
Return on Invested Capital (ROIC)	-213.11%
Return on Capital Employed (ROCE)	23.59%
Weighted Average Cost of Capital (WACC)	7.72%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +113.61% in the last 52 weeks. The beta is 0.99, so GALT's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+113.61%
50-Day Moving Average	3.51
200-Day Moving Average	3.75
Relative Strength Index (RSI)	50.63
Average Volume (20 Days)	225,337

Short Selling Information

The latest short interest is 4.80 million, so 7.44% of the outstanding shares have been sold short.

Short Interest	4.80M
Short Previous Month	4.75M
Short % of Shares Out	7.44%
Short % of Float	10.49%
Short Ratio (days to cover)	11.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.15M
Pretax Income	-37.30M
Net Income	-37.44M
EBITDA	n/a
EBIT	-29.15M
Earnings Per Share (EPS)	-$0.59

Full Income Statement

Balance Sheet

The company has $11.53 million in cash and $126.05 million in debt, with a net cash position of -$114.53 million or -$1.78 per share.

Cash & Cash Equivalents	11.53M
Total Debt	126.05M
Net Cash	-114.53M
Net Cash Per Share	-$1.78
Equity (Book Value)	-123.58M
Book Value Per Share	-1.95
Working Capital	-123.72M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-30.62M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.12%
Shareholder Yield	-2.12%
Earnings Yield	-18.04%
FCF Yield	n/a

Analyst Forecast

The average price target for GALT is $8.50, which is 175.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	175.08%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 23, 2012
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1